AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition
Authors: Chaturvedi, N Fuller, JH Pokras, F Rottiers, R Papazoglou, N Aiello, LP
Citation: N. Chaturvedi et al., Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus: the influence of ACE inhibition, DIABET MED, 18(4), 2001, pp. 288-294
Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study
Authors: Idzior-Walus, B Mattock, MB Solnica, B Stevens, L Fuller, JH
Citation: B. Idzior-walus et al., Factors associated with plasma lipids and lipoproteins in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study, DIABET MED, 18(10), 2001, pp. 786-796
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study
Authors: Mattock, MB Cronin, N Cavallo-Perin, P Idzior-Walus, B Penno, G Bandinelli, S Standl, E Kofinis, A Fuller, JH
Citation: Mb. Mattock et al., Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study, DIABET MED, 18(1), 2001, pp. 59-67
The association of heart-rate variability with cardiovascular risk factorsand coronary artery calcification - A study in type 1 diabetic patients and the general population
Authors: Colhoun, HM Francis, DP Rubens, MB Underwood, SR Fuller, JH
Citation: Hm. Colhoun et al., The association of heart-rate variability with cardiovascular risk factorsand coronary artery calcification - A study in type 1 diabetic patients and the general population, DIABET CARE, 24(6), 2001, pp. 1108-1114
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study (vol 24, pg 316, 2001)
Authors: Crook, MA Pickup, JC Lumb, PJ Georgino, F Webb, DJ Fuller, JH
Citation: Ma. Crook et al., Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study (vol 24, pg 316, 2001), DIABET CARE, 24(5), 2001, pp. 973-973
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study
Authors: Chaturvedi, N Sjoelie, AK Porta, M Aldington, SJ Fuller, JH Songini, M Kohner, EM
Citation: N. Chaturvedi et al., Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study, DIABET CARE, 24(2), 2001, pp. 284-289
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes - The EURODIAB Complications Study
Authors: Crook, MA Pickup, JC Lumb, PJ Georgino, F Webb, DJ Fuller, JH
Citation: Ma. Crook et al., Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes - The EURODIAB Complications Study, DIABET CARE, 24(2), 2001, pp. 316-322
Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes
Authors: Chaturvedi, N Fuller, JH Taskinen, MR
Citation: N. Chaturvedi et al., Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes, DIABET CARE, 24(12), 2001, pp. 2071-2077
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Authors: Chaturvedi, N Bandinelli, S Mangili, R Penno, G Rottiers, RE Fuller, JH
Citation: N. Chaturvedi et al., Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold, KIDNEY INT, 60(1), 2001, pp. 219-227
Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity
Authors: Lee, ET Keen, H Bennett, PH Fuller, JH Lu, M
Citation: Et. Lee et al., Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity, DIABETOLOG, 44, 2001, pp. S3-S13
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
Authors: Morrish, NJ Wang, SL Stevens, LK Fuller, JH Keen, H
Citation: Nj. Morrish et al., Mortality and causes of death in the WHO multinational study of vascular disease in diabetes, DIABETOLOG, 44, 2001, pp. S14-S21
Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes
Authors: Bennett, PH Lee, ET Lu, M Keen, H Fuller, JH
Citation: Ph. Bennett et al., Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes, DIABETOLOG, 44, 2001, pp. S37-S45
Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes
Authors: Colhoun, HM Lee, ET Bennett, PH Lu, M Keen, H Wang, SL Stevens, LK Fuller, JH
Citation: Hm. Colhoun et al., Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes, DIABETOLOG, 44, 2001, pp. S46-S53
Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes.
Authors: Fuller, JH Stevens, LK Wang, SL
Citation: Jh. Fuller et al., Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes., DIABETOLOG, 44, 2001, pp. S54-S64
Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes
Authors: Chaturvedi, N Stevens, LK Fuller, JH Lee, ET Lu, M
Citation: N. Chaturvedi et al., Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes, DIABETOLOG, 44, 2001, pp. S65-S71
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification
Authors: Colhoun, HM Scheek, LM Rubens, MB Van Gent, T Underwood, SR Fuller, JH Van Tol, A
Citation: Hm. Colhoun et al., Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification, DIABETES, 50(3), 2001, pp. 652-659
Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids
Authors: Buyken, AE Toeller, M Heitkamp, G Karamanos, B Rottiers, R Muggeo, M Fuller, JH
Citation: Ae. Buyken et al., Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids, AM J CLIN N, 73(3), 2001, pp. 574-581
A locus influencing total serum cholesterol on chromosome 19p - Results from an autosomal genomic scan of serum lipid concentrations in Pima Indians
Authors: Imperatore, G Knowler, WC Pettitt, DJ Kobes, S Fuller, JH Bennett, PH Hanson, RL
Citation: G. Imperatore et al., A locus influencing total serum cholesterol on chromosome 19p - Results from an autosomal genomic scan of serum lipid concentrations in Pima Indians, ART THROM V, 20(12), 2000, pp. 2651-2656
Cross sectional study of differences in coronary artery calcification by socioeconomic status
Authors: Colhoun, HM Rubens, MB Underwood, SR Fuller, JH
Citation: Hm. Colhoun et al., Cross sectional study of differences in coronary artery calcification by socioeconomic status, BR MED J, 321(7271), 2000, pp. 1262-1263
Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus
Authors: Buyken, AE Toeller, M Heitkamp, G Irsigler, K Holler, C Santeusanio, F Stehle, P Fuller, JH
Citation: Ae. Buyken et al., Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus, DIABET MED, 17(5), 2000, pp. 351-359
The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification
Authors: Colhoun, HM Rubens, MB Underwood, SR Fuller, JH
Citation: Hm. Colhoun et al., The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification, J AM COL C, 36(7), 2000, pp. 2160-2167
Different risk factors of microangiopathy in patients with Type I diabetesmellitus of short versus long duration. The EURODIAB IDDM Complications Study
Authors: Karamanos, B Porta, M Songini, M Metelko, Z Kerenyi, Z Tamas, G Rottiers, R Stevens, LK Fuller, JH
Citation: B. Karamanos et al., Different risk factors of microangiopathy in patients with Type I diabetesmellitus of short versus long duration. The EURODIAB IDDM Complications Study, DIABETOLOG, 43(3), 2000, pp. 348-355
Differences in HDL-cholesterol : apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
Authors: Soedamah-Muthu, SS Colhoun, HM Taskinen, MR Idzior-Walus, B Fuller, JH
Citation: Ss. Soedamah-muthu et al., Differences in HDL-cholesterol : apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients, DIABETOLOG, 43(11), 2000, pp. 1353-1359
Blood pressure and diabetes mellitus
Authors: Colhoun, HM Fuller, JH
Citation: Hm. Colhoun et Jh. Fuller, Blood pressure and diabetes mellitus, HBK HYPERT, 20, 2000, pp. 489-508
Associations of fat and cholesterol intake with serum lipid levels and cardiovascular disease: The EURODIAB IDDM Complications Study
Authors: Toeller, M Buyken, AE Heitkamp, G Scherbaum, WA Krans, HMJ Fuller, JH
Citation: M. Toeller et al., Associations of fat and cholesterol intake with serum lipid levels and cardiovascular disease: The EURODIAB IDDM Complications Study, EXP CL E D, 107(8), 1999, pp. 512-521
Risultati: 1-25 | 26-29